Cushing's Syndrome clinical trials at UCSF
1 research study open to eligible people
Cushing's syndrome is a condition where the body makes too much cortisol. UCSF is studying how a medicine called osilodrostat works in kids with this condition. The study looks at how the medicine is absorbed and tolerated by the body.
Showing trials for
(PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
open to eligible people ages 2-17
Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's syndrome.
San Francisco, California and other locations
Last updated: